Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadone Subjects
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
MOA-728, an investigational drug, is currently being studied for the relief of constipation
associated with postoperative ileus and treatment of opioid induced constipation in patients
receiving palliative care. This study will further investigate the IV formulation of MOA-728
comparing PK/PD time points for a 20-minute versus a 4-hour infusion.
Phase:
Phase 1
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.